Access

Article

Nature 405, 914-919 (22 June 2000) | doi:10.1038/35016007; Received 14 March 2000; Accepted 4 May 2000

Open Innovation Challenges

naturejobs

Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export

Vassilis Koronakis1,2, Andrew Sharff2,3, Eva Koronakis1, Ben Luisi3 & Colin Hughes1

  1. Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK
  2. Crystallography & Biocomputing Unit, Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, UK
  3. These authors contributed equally to this work

Correspondence to: Vassilis Koronakis1,2 Correspondence and requests for materials should be addressed to V.K. (e-mail: Email: vk103@mole.bio.cam.ac.uk). Coordinates have been deposited in the RCSB protein data bank under accession code 1EK9.

Top

Diverse molecules, from small antibacterial drugs to large protein toxins, are exported directly across both cell membranes of Gram-negative bacteria. This export is brought about by the reversible interaction of substrate-specific inner-membrane proteins with an outer-membrane protein of the TolC family, thus bypassing the intervening periplasm. Here we report the 2.1-Å crystal structure of TolC from Escherichia coli, revealing a distinctive and previously unknown fold. Three TolC protomers assemble to form a continuous, solvent-accessible conduit—a 'channel-tunnel' over 140 Å long that spans both the outer membrane and periplasmic space. The periplasmic or proximal end of the tunnel is sealed by sets of coiled helices. We suggest these could be untwisted by an allosteric mechanism, mediated by protein–protein interactions, to open the tunnel. The structure provides an explanation of how the cell cytosol is connected to the external environment during export, and suggests a general mechanism for the action of bacterial efflux pumps.